Sulfuric Acid

Sulfuric Acid

SCHEMBL2295168

O.O.O.O.O.O.O.O.O=S(=O)([O-])[O-].O=S(=O)([O-])[O-].O=S(=O)([O-])[O-].[Tb+3].[Tb+3]

nearest known ligand 0.42

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

dacAdacBdacCftsImrcAmrcBmrdA

The experimentally established mechanism targets of Sulfuric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.42
ALDH1A1 P00352 1/20 0.42
TSHR P16473 1/20 0.42
KMT2A Q03164 1/20 0.42
TP53 P04637 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Sulfuric Acid SCHEMBL1088028 0.94 MEN1 (0.46) MEN1ALDH1A1TSHRKMT2ATP53
Sulfuric Acid SCHEMBL21840697 0.88 MEN1 (0.42) MEN1ALDH1A1TSHRKMT2ATP53
Sulfuric Acid SCHEMBL21485076 0.88 MEN1 (0.42) MEN1ALDH1A1TSHRKMT2ATP53
Sulfuric Acid SCHEMBL22203986 0.88 MEN1 (0.42) MEN1ALDH1A1TSHRKMT2ATP53
Sulfuric Acid SCHEMBL23294054 0.88 MEN1 (0.42) MEN1ALDH1A1TSHRKMT2ATP53
Sulfuric Acid SCHEMBL23397440 0.88 MEN1 (0.42) MEN1ALDH1A1TSHRKMT2ATP53
Sulfuric Acid SCHEMBL23827344 0.88 MEN1 (0.42) MEN1ALDH1A1TSHRKMT2ATP53
Sulfuric Acid SCHEMBL25265024 0.88 MEN1 (0.42) MEN1ALDH1A1TSHRKMT2ATP53
Sulfuric Acid SCHEMBL22499921 0.88 ALDH1A1 (0.55) MEN1ALDH1A1TSHRKMT2ATP53
Sulfuric Acid SCHEMBL25407166 0.88 MEN1 (0.42) MEN1ALDH1A1TSHRKMT2ATP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-122080428-A Metal organic framework material for detecting copper ions and preparation method and application thereof 2026-05-26 CN claimed
CN-120040781-A One-dimensional Tb (III) coordination polymer and preparation method and application thereof 中国科学院赣江创新研究院 2025-05-27 CN claimed
CN-122080428-A Metal organic framework material for detecting copper ions and preparation method and application thereof 2026-05-26 CN disclosed
CN-120040781-A One-dimensional Tb (III) coordination polymer and preparation method and application thereof 中国科学院赣江创新研究院 2025-05-27 CN disclosed
CN-118825307-A Rare earth element doped carbon nitride supported noble metal electrocatalyst and preparation method and application thereof 北京师范大学珠海校区 2024-10-22 CN disclosed
US-8226844-B2 Biocompatible magnetic nanocrystal, powder of a biocompatible magnetic nanocrystal bearing a surface reactive group and preparations thereof INSTITUTE OF CHEMISTRY, CHINESE ACADEMY OF SCIENCES (CN) 2012-07-24 US disclosed
US-8017031-B2 Biocompatible magnetic nanocrystal, powder of a biocompatible magnetic nanocrystal bearing a surface reactive group and preparations thereof INSTITUTE OF CHEMISTRY, CHINESE ACADEMY OF SCIENCES (CN) 2011-09-13 US disclosed
US-20110207894-A1 BIOCOMPATIBLE MAGNETIC NANOCRYSTAL, POWDER OF A BIOCOMPATIBLE MAGNETIC NANOCRYSTAL BEARING A SURFACE REACTIVE GROUP AND PREPARATIONS THEREOF INSTITUTE OF CHEMISTRY CHINESE ACADEMY OF SCIENCES (CN) 2011-08-25 US disclosed
US-20080203351-A1 paramagnetic or ferromagnetic crystals highly soluble and dispersible in buffers, bonded with a biocompatible macromolecule and an alkyl-containing molecule simultaneously, or a biocompatible macromolecule alone; storage stability INSTITUTE OF CHEMISTRY, CHINESE ACADEMY OF SCIENCES (CN) 2008-08-28 US disclosed
EP-0330799-A1 A method for the treatment of arthritis and inflammatory joint diseases SCHERING AKTIENGESELLSCHAFT (DE) 1989-09-06 EP disclosed
EP-0330801-A1 Ferromagnetic, diamagnetic or paramagnetic particles useful in the diagnosis and treatment of disease SCHERING AKTIENGESELLSCHAFT (DE) 1989-09-06 EP disclosed